Germany's CureVac to launch human trial of experimental coronavirus vaccine

Reuters

17 June, 2020, 03:35 pm

Last modified: 17 June, 2020, 03:39 pm

Germany's CureVac to launch human trial of experimental coronavirus vaccine

It was reported that Paul Ehrlich Institut would approve testing on humans of the experimental vaccine

Reuters

17 June, 2020, 03:35 pm

Last modified: 17 June, 2020, 03:39 pm

Representational Image. Photo: Reuters

Representational Image. Photo: Reuters

Unlisted German biotech firm CureVac will become the second company to launch human trials of an experimental coronavirus vaccine in the country, Germany's vaccines regulator said on Wednesday.

Reuters reported on Tuesday that the watchdog, the Paul Ehrlich Institut, would approve testing on humans of the experimental vaccine.

Keep updated, follow The Business Standard's Google news channel

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Unlike other halls, the International Hall exclusively houses foreign students. Photos: Junayet Rashel

The ‘national’ interest in DU’s ‘international’ hall

10h | Panorama

Photo: Microsoft

Windows 365 Link: A new era for cloud computing?

9h | Tech

Photo: Le Reve

Winter escapes and stylish layers

15h | Mode

Photo: Collected

From dance hall to hotel to hospital: The story of Hotel Shahbagh

20h | Features

Met office forecasts rain likely over parts of country

Met office forecasts rain likely over parts of country

11h | Videos

How the bullet train transformed Japan

How the bullet train transformed Japan

11h | Videos

Should the Fab Five have their jersey numbers retired?

Should the Fab Five have their jersey numbers retired?

1d | Videos

West Bengal government removes obstacles in potato and onion exports

West Bengal government removes obstacles in potato and onion exports

1d | Videos